Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease
Positive Influence of Behavior Change Communication on Knowledge, Attitudes, and Practices for Visceral Leishmaniasis/Kala-azar in India
Study from India illustrating the importance of community engagement and health promotion activities within VL elimination programs. "Households that were exposed to community-based BCC activities largely using group and interpersonal communication had better knowledge, attitudes, and practices related to VL, including acceptance of IRS as a preventive measure, than households not exposed".
A map of the ethical issues around vector-borne diseases (23-24 February 2017), including:
- environmental and social determinants of health
- ethics of vector control
- aspects of ethics in surveillance and research
- ethics of mass public health interventions
“Kala-Azar is a Dishonest Disease”: Community Perspectives on Access Barriers to Visceral Leishmaniasis (Kala-Azar) Diagnosis and Care in Southern Gadarif, Sudan
Early diagnosis and treatment is the principal strategy to control visceral leishmaniasis (VL), or kala-azar in East Africa. As VL strikes remote rural, sparsely populated areas, kala-azar care might not be accessed optimally or timely. We conducted a qualitative study to explore access barriers in a longstanding kala-azar endemic area in southern Gadarif, Sudan. Former kala-azar patients or caretakers, community leaders, and health-care providers were purposively sampled and thematic data analysis was used. Our study participants revealed the multitude of difficulties faced when seeking care. The disease is well known in the area, yet misconceptions about causes and transmission persist. The care-seeking itineraries were not always straightforward: “shopping around” for treatments are common, partly linked to difficulties in diagnosing kala-azar. Kala-azar is perceived to be “hiding,” requiring multiple tests and other diseases must be treated first. Negative perceptions on quality of care in the public hospitals prevail, with the unavailability of drugs or staff as the main concern. Delay to seek care remains predominantly linked to economic constraint: albeit treatment is for free, patients have to pay out of pocket for everything else, pushing families further into poverty. Despite increased efforts to tackle the disease over the years, access to quality kala-azar care in this rural Sudanese context remains problematic. The barriers explored in this study are a compelling reminder of the need to boost efforts to address these barriers.
Presentations & Materials from KalaCORE Regional Technical Review Meeting: VL control programme overview
From November 29 – December 1 2017, KalaCORE hosted a Regional Technical Review Meeting and Workshop in Addis Ababa, Ethiopia, with representatives from the National Ministry of Health from all 3 KalaCORE-supported country programmes in Africa, DFID Ethiopia and DFID UK, KalaCORE implementing partners, WHO Geneva, WHO Sudan, WHO South Sudan and WHO Ethiopia, the KalaCORE Expert Steering Group, the NTD task force and the NGDO NTD task force.
The meeting succeeded in documenting lessons learned and improvement actions for current strategies across KalaCORE country contexts, prioritising activities for the remainder of the programme, sharing operational research findings for policy implementation, and initiating the pathway for developing the KalaCORE exit strategy and integration of key activities for sustainability.